跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENALIDOMIDA KRKA 2,5 mg CÁPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LENALIDOMIDA KRKA 2,5 mg CÁPSULAS DURAS EFG
Approved
STANDARD
LENALIDOMIDA KRKA 2,5 mg CÁPSULAS DURAS EFG
Krka D.D. Novo Mesto
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 19, 2021
Approval ID
937a9425f71ace77
Company
Krka D.D. Novo Mesto
Type
Standard
Approval Details
Approval Id
937a9425f71ace77
Drug Cima Aemps Name
LENALIDOMIDA KRKA 2,5 mg CÁPSULAS DURAS EFG
Register Number
1201519002
Holder Company Name
Krka D.D. Novo Mesto
Marketing Company Name
Krka Farmaceutica S.L.
Authorization Date
2021-03-19
Dosage Form
CÁPSULA DURA
Dose
2.5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Krka D.D. Novo Mesto
Active Ingredients
LENALIDOMIDA HIDROCLORURO HIDRATO
3,03 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 19, 2021
Approval ID
937a9425f71ace77
Type
Standard
Back to CIMA-AEMPS Approvals
